Log in to your Inderes Free account to see all free content on this page.
SoftOx Solutions
Be the first to follow this company
SoftOx Solutions is a Norwegian medical technology company. The company has developed a self-patented solution based on acetic acid for the treatment of chronic wounds in patients. The solution is used to eliminate infections associated with biofilms, which consist of different clusters of bacteria. Part of the drug development takes place in collaboration with other research institutes. SoftOx Solutions was established in 2012 and is headquartered in Oslo.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Euronext Growth Oslo
SOFTX
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Extraordinary general meeting
31.07.2024
Interim report
25.09.2024
Interim report
27.11.2024
Annual report
05.03.2025
General meeting
25.06.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Dinge Invest | 10.8 % | 10.8 % |
Nordnet Livforsikring AS | 10.7 % | 10.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
SoftOx Solution AS: KEY INFORMATION RELATING TO THE PREFERENTIAL RIGHTS ISSUE TO BE CARRIED OUT BY SOFTOX SOLUTIONS AS
SoftOx Solution AS: Proposed Rights Issue and summons for Extraordinary General Meeting on the 31th of July 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio